Back to Research

Organization profile

Korify Capital

Korify Capital is a Basel-based venture capital firm focused on breakthrough technologies in longevity and mental health. It is the specialized investment arm of the Swiss family office Infinitas Capital.18

Basel, SwitzerlandFounded 2021

Overview

1. Executive Summary (Confidence: High)

Korify Capital is a strategic financier in the global longevity ecosystem, managing the $100 million "Korify Capital Fund ONE". The firm invests in Series A–C rounds, specifically targeting companies that address the biological drivers of aging and the low response rates of traditional mental health treatments. Korify’s investment thesis is centered on "Maintaining health and preventing illness," utilizing AI and genomics to accelerate drug discovery. With "anchor" investments in Cambrian Biopharma and Alto Neuroscience, Korify has demonstrated a track record of identifying future market leaders, including companies that have achieved successful public listings.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.